Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Anaconda Biomed Gets FDA IDE Nod for ATHENA Study - Medical Product Outsourcing
OEM News

Anaconda Biomed Gets FDA IDE Nod for ATHENA Study

The study will assess the ANA Funnel Catheter for mechanical thrombectomy in combination with a stent retriever.

Anaconda Biomed has obtained conditional investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to start the ATHENA study of its ANA Funnel Catheter.

The study will assess the ANA Funnel Catheter’s safety and effectiveness of mechanical thrombectomy in combination with a stent retriever. Once approved by the Institutional Review Board (IRB), the study will be hosted at up to 40 U.S. and international centers, enrolling patients with acute ischemic stroke and treated within a day of symptom onset.

The study will report acute reperfusion success after a single thrombectomy pass with three of the most commonly used stent retrievers, as well as on procedural safety between study arms.

The ANA (Advanced Neurovascular Access) Funnel Catheter assists in neurovascular procedures by assisting delivery of stent retrievers and catheters. It’s comprised of a radiopaque Nitinol braid with a silicone coating to allow local flow arrest.

“The IDE approval marks an exciting milestone in our company’s mission to deliver new, safe and effective solutions that can meaningfully improve the treatment of stroke,” said Anaconda Biomed CEO Francois Salmon. “We believe the ANA Funnel Catheter has the potential to transform the treatment of acute ischemic stroke, improving neurological outcomes and benefiting countless patients.”

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters